Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2012
09/19/2012CN101322739B Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique
09/18/2012US8269040 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
09/18/2012US8269008 Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions
09/18/2012US8268857 Compositions and methods for inhibiting TGF-β
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268839 Compounds
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268779 Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012CA2666764C Long-term enteral feed for maintenance
09/18/2012CA2525486C Composition for lowering the internal lipid
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2479659C Choline-silicic acid complex with osmolytes and divalent trace elements
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2405731C Compositions and methods for improving vascular health
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/18/2012CA2378943C Super-active porcine growth hormone releasing hormone analog
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122264A1 Oxaspiro [2.5] octane derivatives and analogs
09/13/2012WO2012122107A2 Apparatus, system, and method for creating biologically protected/enhanced spaces in vivo
09/13/2012WO2012121596A1 Use of vanadium compounds for maintaining normaglycemia in a mammal
09/13/2012WO2012121461A1 Stable fast-dissolving film formulation for oral dosage form
09/13/2012WO2012121423A1 Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012121095A1 Enteral nutrient
09/13/2012WO2012121080A1 Metabolic syndrome ameliorating agent
09/13/2012WO2012120476A1 Substituted morpholines as modulators for the calcium sensing receptor
09/13/2012WO2012120262A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
09/13/2012WO2012120236A1 Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot
09/13/2012WO2012120058A1 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120057A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012WO2012120056A1 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/13/2012WO2012120055A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120053A1 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012120052A1 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
09/13/2012WO2012120051A1 Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
09/13/2012WO2012120050A1 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
09/13/2012WO2012120048A1 Tfeb phosphorylation inhibitors and uses thereof
09/13/2012WO2012119979A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012119883A1 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors
09/13/2012WO2012119550A1 C-glucosidase derivative having cyclopropane structure, preparing method therefor, pharmaceutical composition, and use thereof
09/13/2012WO2012119265A1 NOVEL ESTERS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR DISEASE THERAPIES
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2012070905A3 Mollusk extract for preventing or treating rare and intractable diseases of the human body
09/13/2012WO2012067427A3 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
09/13/2012WO2012053003A8 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232143 Lipid derivatives
09/13/2012US20120232122 Tricyclic heterocyclic derivatives
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120232118 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232109 3-substituted sulfonyl piperidine derivative
09/13/2012US20120232107 Non-peptide antagonists of gastrin releasing peptide
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232096 Benzofuran derivatives
09/13/2012US20120232095 Benzofuran derivatives
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232084 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
09/13/2012US20120232078 Novel Medicaments
09/13/2012US20120232073 Fused bicyclic pyrimidine derivatives and methods of use thereof
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232056 Heterocyclic compounds for the inhibition of pask
09/13/2012US20120232051 3-amino-pyridines as gpbar1 agonists
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232037 Treatment of obesity, metabolic syndrome, and diabetes with protein kinase c inhibitors
09/13/2012US20120232023 Whey protein product and a method for its preparation
09/13/2012US20120232021 Peptide linkers for polypeptide compositions and methods for using same
09/13/2012US20120232011 Use of Rapamycin and Rapamycin Derivatives for the Treatment of Bone Loss
09/13/2012US20120232005 Lipoprotein complexes and manufacturing and uses thereof
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120232003 Compositions and methods for diabetes treatment
09/13/2012US20120232002 Slow-acting insulin preparations
09/13/2012US20120232001 Stable formulations for parenteral injection of peptide drugs
09/13/2012US20120231999 Peptidic glp-2 agonists
09/13/2012US20120231098 Weight loss composition
09/13/2012US20120231095 Agents derived from holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231067 Vesicle compositions
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231011 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120230998 Ip-10 antibodies and their uses
09/13/2012US20120230987 Methods for treating conditions associated with c-fms
09/13/2012US20120230955 Arabinoxylans for modulating the barrier function of the intestinal surface
09/13/2012US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability
09/13/2012US20120230943 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
09/13/2012US20120230941 Methods for treating nervous system injury and disease
09/13/2012US20120230922 Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012CA2830706A1 Quinolinone derivatives
09/13/2012CA2829259A1 Use of vanadium compounds for maintaining normaglycemia in a mammal
09/13/2012CA2829204A1 Oxaspiro[2.5]octane derivatives and analogs
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 1298